Purdue University chemist David Nichols says he never intended for the compounds he invented to become harmful street drugs, reports the Associated Press's Seth Borenstein. Chemicals Nichols made as possible treatments to Parkinson's disease or depression, and which were roughly similar to ecstasy and LSD, have been exploited by black market labs as recreational drugs instead, Borenstein says.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.